Skip to main content
Colorectal Cancer, Immunotherapy
Nivolumab-Ipilimumab Combination Highly Active in Metastatic MSI-H or dMMR Colorectal Cancer
Read More
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery
Read More
Supportive Care
Managing Bone Metastases Through a Multidisciplinary Approach
Meg Barbor, MPH
Read More
FDA Updates
Braftovi Plus Mektovi a New Combination for Unresectable or Metastatic Melanoma with BRAF Mutation
Read More
Cannabis for Symptom Management in Cancer: Do You Know What Your Patients Are Using?
Read More
Immunotherapy
Building on the Successes of Cancer Immunotherapy
Charles Bankhead
Read More
Drug Resistance
Oral Toxicities Associated with Cancer Therapies: What’s Old Is New Again
Meg Barbor, MPH
Read More
TLR9 Agonist plus Immunotherapy May Overcome Resistance to PD-1 Inhibition
Phoebe Starr
Read More
FDA Updates
Lenvima Now Approved for Unresectable Hepatocellular Carcinoma
Read More
Immunotherapy
Nivolumab plus Ipilimumab Combo Controls Brain Metastases in Patients with Skin Cancer
Phoebe Starr
Read More
Page 154 of 196
Results 1531 - 1540 of 1954